Epidemiology, patient management, and survival outcomes in resected patients with non-metastatic non-small cell lung cancer: a nationwide real-world study
- Published on 06/03/2025
- Reading time: 5 min.
Renaud Stéphane 1, Casabianca Paul 2, Diez-Andreu Pauline 3, Chartier Mélanie 2, Gaudin Anne-Françoise 2, Bugnard Françoise 3, Bénard Stève 3, Cotté François-Emery 2, Chouaid Christos 4
1 https://ror.org/016ncsr12 Thoracic surgery department CHRU Nancy 29 avenue du Maréchal de Lattre de Tassigny 54000 Nancy France
2 https://ror.org/013b57229 Health Economics and Outcomes Research, Bristol Myers Squibb 3 Rue Joseph Monier 92506 Rueil-Malmaison France
3 stève consultants a Cytel company, 30 Rue Narcisse Bertholey 69600 Oullins-Pierre-Bénite France
4 https://ror.org/04n1nkp35 Pneumology department CHI Créteil 40 avenue de Verdun 94000 Créteil France
Abstract
Introduction Surgery is the standard of care for eligible patients with localized or stage IIIA locally advanced non-small cell lung cancer (NSCLC) current guidelines recommend the most conservative surgeries possible. The aim of this study was to bring new real-world data on resected NSCLC epidemiology, management, and survival outcomes in patients with resected non-metastatic NSCLC.
Materials and methods This is a descriptive, non-interventional, national,...
To continue reading this article in Full-Text...
Peer-Reviewed Journals A-Z
Search | Advanced search
Get the latest news in Oncology
Receive our newsletter to stay up to date with the latest news in Oncology
